Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (351-360 of 646) with videos related to

Pageof 65
Sort By:
Chest|January 16, 2007
Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPDThérèse S Lapperre, Luuk N A Willems, Wim Timens, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 18, 2024
The epithelial era of asthma research: knowledge gaps and future direction for patient careChristopher E Brightling, Gianni Marone, Helena Aegerter, et al.
Chest|March 12, 2003
Bilateral cavitary pulmonary consolidations in a patient undergoing allogeneic bone marrow transplantation for acute leukemiaThyo J N Hiltermann, Robbert G M Bredius, Birthe J Gesink-vd Veer, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2004
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysKlaus F Rabe, Mitsuru Adachi, Christopher K W Lai, et al.
Pneumologie (Stuttgart, Germany)|November 17, 2006
[Clinical significance of gastrooesophageal reflux in asthma]T Rothe, R Buhl, A Gillissen, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
The New England Journal of Medicine|June 28, 2018
Combined Analysis of Asthma Safety Trials of Long-Acting β<sub>2</sub>-AgonistsWilliam W Busse, Eric D Bateman, Arthur L Caplan, et al.
ERJ Open Research|December 17, 2025
Short-acting β<sub>2</sub>-agonist use, exacerbation risk and triple therapy in COPD: <i>post hoc</i> analyses of ETHOSJohn R Hurst, Dave Singh, Fernando J Martinez, et al.
Therapeutic Advances in Respiratory Disease|July 11, 2022
Predictive modeling of COPD exacerbation rates using baseline risk factorsDave Singh, John R Hurst, Fernando J Martinez, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 31, 2016
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study designStephen I Rennard, Fernando J Martinez, Klaus F Rabe, et al.
Pageof 65

Showing results (351-360 of 646) with videos related to

Sort By:
Pageof 65
Chest|January 16, 2007
Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPDThérèse S Lapperre, Luuk N A Willems, Wim Timens, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 18, 2024
The epithelial era of asthma research: knowledge gaps and future direction for patient careChristopher E Brightling, Gianni Marone, Helena Aegerter, et al.
Chest|March 12, 2003
Bilateral cavitary pulmonary consolidations in a patient undergoing allogeneic bone marrow transplantation for acute leukemiaThyo J N Hiltermann, Robbert G M Bredius, Birthe J Gesink-vd Veer, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2004
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysKlaus F Rabe, Mitsuru Adachi, Christopher K W Lai, et al.
Pneumologie (Stuttgart, Germany)|November 17, 2006
[Clinical significance of gastrooesophageal reflux in asthma]T Rothe, R Buhl, A Gillissen, et al.
Respiratory Research|July 11, 2020
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trialKlaus F Rabe, David M G Halpin, MeiLan K Han, et al.
The New England Journal of Medicine|June 28, 2018
Combined Analysis of Asthma Safety Trials of Long-Acting β<sub>2</sub>-AgonistsWilliam W Busse, Eric D Bateman, Arthur L Caplan, et al.
ERJ Open Research|December 17, 2025
Short-acting β<sub>2</sub>-agonist use, exacerbation risk and triple therapy in COPD: <i>post hoc</i> analyses of ETHOSJohn R Hurst, Dave Singh, Fernando J Martinez, et al.
Therapeutic Advances in Respiratory Disease|July 11, 2022
Predictive modeling of COPD exacerbation rates using baseline risk factorsDave Singh, John R Hurst, Fernando J Martinez, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 31, 2016
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study designStephen I Rennard, Fernando J Martinez, Klaus F Rabe, et al.
Pageof 65